Arkolith/Insider Trading/CAI/Form 4

Spetzler David Baxley

PresidentCaris Life Sciences, Inc. (CAI) · full profile →Form 4 · filed Jun 23, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 20, 2025Tax withholding(F)35K$27.25$948K524K
Jun 20, 2025Option exercise(M)75K$2.44$183K559K
Jun 18, 2025Grant(A)132K—$0484K
Mar 3, 2025Disposed to issuer(D)701K$18.60$13.0M351K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 20, 2025Option exercise(M)75K—$00
Mar 3, 2025Grant(A)750K—$0750K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion
A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-061815) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML